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Prognostic Value of Bone
Scintigraphy in Cancer
Patients With
Osteonecrosis of the Jaw
Is There Something Missing?
To the Editor:
W ith great interest, I read the article byVan den Wyngaert et al1 published in
Clinical Nuclear Medicine (2011;36:17Y20).
Better late than never.
The authors reported on the potential de-
tection of bisphosphonate osteonecrosis of
the jaw (BP ONJ) using bone scintigraphy.
They performed planar bone scintigraphy and
SPECT in 22 patients with stage 1 to 3
BP ONJ and postulated that SPECT will de-
tect BP ONJ lesions and provide prognostic
information.
Apart from the very limited number of
patients and sample power, there is something
missing in the interpretation of results, which,
in my opinion, ought to be resolved.
Bone scintigraphy as such, including
SPECT acquisition, represents a surrogate pa-
rameter reﬂecting osteoblasts’ activity by tracer
uptake in ROI. This is, in turn, the hallmark
of osteomyelitic changes or a sign of repara-
tive process after trauma, surgery, and bone
remodeling.2Y4
Although the pathogenesis of BP ONJ
is not yet completely understood, it is assumed
that this condition is related to alteration of
bone remodeling because of the inhibition of
osteoclast function and bone turnover.5
Taking these aspects into consideration,
the ﬁndings presented in this study are ‘‘non-
speciﬁc’’ in the sense of not being related to
osteonecrosis, which is ‘‘invisible’’ by bone
scintigraphy, but to the more or less associated
osteomyelitic lesion or reparative process. This
is, at the same time, the simple explanation
of the inhomogeneous distribution of scinti-
graphic ﬁndings among the 3 groups, namely
the lesions induced various types of inﬂamma-
tory and reparative changes in the affected bone.
I found the article by Van den Wyngaert
et al very interesting; apparently, the reviewer
did so too. However, I missed this critical as-
pect in the discussion and had to make up for
the readers of Clinical Nuclear Medicine.
Samer George Hakim, MD, DMD, PhD
Department of Oral and Maxillofacial Surgery
University of Luebeck
Luebeck, Germany
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Macroaggregated
Albumin (MAA) Injected
in Hepatic Artery
Visualized in a Recanalized
Paraumbilical Vein
To the Editor:
I read the article titled ‘‘Macroaggregated al-bumin (MAA) injected in hepatic artery
visualized in a recanalized paraumbilical
vein’’ by Gupta et al1 with great interest. Lo-
calization mechanism of 99mTc-MAA is re-
lated to the particle size of MAA (usually
30Y50 Km), which is larger than the size of
the capillary. When the particles infused into
the hepatic artery, they distribute according to
blood ﬂow and are trapped on ﬁrst pass in the
arteriolar-capillary bed of the liver. Therefore,
the 99mTc-MAA hepatic arterial scintigraphy
can help to determine the possibility and
amount of extrahepatic perfusion by intrahe-
patic infusion of 90Ymicrospheres, which gives
rise to systemic toxicity.
The report by Hsieh et al,2 introduced on
the interesting image, had demonstrated vi-
sualization of the portosystemic collateral
circulation with 99mTc RBC scintigraphy and
it is natural because of the localization
mechanism of 99mTc RBC in blood vessels.
The case report by Chernyak et al3 visualized
focal tracer uptake at the abdominal wall with
99mTc-MAA scintigraphy. It might be possi-
ble by 99mTc-MAA accumulation in a small
area of the abdominal wall by its possible
blood supply from the patent hepatic falci-
form artery.
Owing to the localization mechanism
of the 99mTc-MAA particle, the particles
which arrived at paraumbilical vein should
ﬂow away to next arteriolar-capillary beds.
Therefore, an uptake mechanism of the 99mTc-
MAA at the recanalized large paraumbilical
vein on the SPECT imaging of the interesting
image is not obvious and hard to be conjec-
tured. Readers of the interesting image might
be more curious about the reason of MAA
retention in the paraumbilical vein, and hope-
fully, it will be answered or suggested by the
authors.
Byeong-Cheol Ahn, MD, PhD
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Myocardial Perfusion
Scintigraphy After Cardiac
Arrest: On the
Pathophysiology of
Cardiac Death
To the Editor:
L ima et al
1 presented a 74-year-old man
who showed extensive ischemia associ-
ated with cardiac arrest during exercise stress
myocardial perfusion scintigraphy (MPI). The
authors concluded that MPI after cardiac ar-
rest is able to illustrate the pathophysiology
of cardiac death.
To expand further on this point, we
would like to add a rare experience in which
MPI was able to show the consequence of
cardiac death during cardiac arrest.
This is a 48-year-old woman who was
referred to our department to be assessed for
coronary artery disease. She had been hospi-
talized because of diabetic foot. She also had a
history of hypertension.
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The patient underwent dipyridamole 99mTc
followed by gated myocardial perfusion imag-
ing (MPI) 90 minutes later. During image ac-
quisition (at frame 59 of 64), she showed cardiac
arrest with asystolic cardiac rhythm. Cardio-
pulmonary resuscitation was started immedi-
ately, and it was successful.
The MPI showed decreased perfusion of
most left ventricle segments and just preserved
septal and anteroseptal walls (Fig. 1).
This is a rare report of cardiac arrest
1.5 hours after dipyridamole stress, which was
recorded by a gamma camera.
This report emphasized the unique role of
MPI in showing real-time cardiac arrest. In
addition, it depicted the value of patient mon-
itoring during the recovery period even after
dipyridamole stress.
Hamid Javadi, MD
Golestan Research Center of
Gastroenterology and Hepatology
Golestan University of Medical Sciences
Gorgan, Iran
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FIGURE 1. A and B, Dipyridamole 99mTc-MIBI MPI SPECT images of a 48-year-old patient showing severe perfusion defects in the most left
ventricle segments. Just the septal and anteroseptal walls were preserved.
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